Atlas Trials

Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

Clinical trial NCT00976755 · COMPLETED

Trial details

NCT number
NCT00976755
Sponsor
Swiss Cancer Institute
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2009-09-14
Primary completion
2012-11-29
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.